◆英語タイトル:Dottikon ES Holding AG (DESN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9843
◆発行会社(調査会社):
GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Dottikon ES Holding AG (Dottikon) manufactures and commercializes active pharmaceutical ingredients (APIs), performance chemicals and intermediates for chemical and pharmaceutical industries. The company finds novel uses for hazardous reactions and continuous processing that facilitate the reduction of chemical synthesis routes, increase output and minimize waste. Dottikon uses its technology to design, develop and optimize chemical processes, and increase production from kilograms to tons. It also offers high-purity isosorbide dimethyl ether, which finds application in cosmetics, pharmaceutical, chemical and agricultural industries. Dottikon also provides recycling and waste management services including recycling of solvents and waste water treatment and purification. The company operates through Dottikon ES Group with a presence in North America, Europe and Asia-Pacific. Dottikon is headquartered in Dottikon, Aargau, Switzerland.
Dottikon ES Holding AG (DESN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dottikon ES Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Bachem and Dottikon Enter into Agreement 9
Acquisition 10
Dottikon Acquires Additional 13.1% Stake in Systag 10
Evolma Holding Acquires 50.09% Stake In Dottikon Es Holding 11
Dottikon ES Holding AG – Key Competitors 12
Dottikon ES Holding AG – Key Employees 13
Dottikon ES Holding AG – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Recent Developments 15
Financial Announcements 15
May 31, 2018: DOTTIKON ES – Higher Investments, Net Sales, and Net Income 15
Nov 28, 2017: DOTTIKON – Higher Sales, Growth Impacts Margins 17
Nov 23, 2017: DOTTIKON ES Group: Condensed Half-Year Report 19
May 30, 2017: DOTTIKON ES – Strong Sales and Income Growth and Higher Profitability 21
Corporate Communications 23
Mar 28, 2017: DOTTIKON Appoints Additional Senior Management Member 23
Legal and Regulatory 24
Oct 11, 2017: DOTTIKON ES Changes to Swiss GAAP FER as of April 1, 2018 24
Jul 07, 2017: DOTTIKON ES to Change from IFRS to Swiss GAAP FER 25
Other Significant Developments 26
Jul 07, 2017: DOTTIKON ES’ Shareholders Approve all Proposals of the Board of Directors 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27
List of Tables
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dottikon ES Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Bachem and Dottikon Enter into Agreement 9
Dottikon Acquires Additional 13.1% Stake in Systag 10
Evolma Holding Acquires 50.09% Stake In Dottikon Es Holding 11
Dottikon ES Holding AG, Key Competitors 12
Dottikon ES Holding AG, Key Employees 13
Dottikon ES Holding AG, Subsidiaries 14
List of Figures
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7